When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Cara Therapeutics (NASDAQ:CARA): despite Covid-19 disruptions, remains on track to report topline data from the Phase 3 KALM-2 study of Korsuva (difelikefalin) in hemodialysis patients with moderate-to-severe chronic kidney disease-associated pruritis (itchy skin) next quarter. It expects to file its U.S. marketing application in H2. Also, it expects to complete an interim statistical analysis for the ongoing Phase 2 trial in atopic dermatitis next quarter.
More news on: Cara Therapeutics, Inc., Hill-Rom Holdings, Inc., Humana Inc., Healthcare stocks news, Stocks on the move,